Nasdaq Otlk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq otlk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Otlk Today - Breaking & Trending Today
Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its price target upped by HC Wainwright to $30.00 in a research note released on Monday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Outlook Therapeutics’ Q2 2024 earnings at ($0.95) EPS, Q3 2024 earnings at ($1.09) […] ....
Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The […] ....
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – Equities researchers at Chardan Capital issued their FY2025 earnings per share (EPS) estimates for Outlook Therapeutics in a research report issued to clients and investors on Thursday, February 15th. Chardan Capital analyst D. Gataulin forecasts that the company will post earnings per share of ($0.10) for the […] ....
Brookline Capital Management upgraded shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday, Benzinga reports. They currently have $1.57 price target on the stock. Other research analysts also recently issued research reports about the stock. Guggenheim upgraded shares of […] ....
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) has earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among analysts […] ....